First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Sets New 12-Month High – Here’s What Happened

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) reached a new 52-week high during mid-day trading on Monday . The company traded as high as $258.25 and last traded at $257.6450, with a volume of 6813 shares. The stock had previously closed at $255.93.

First Trust NYSE Arca Biotechnology Index Fund Stock Performance

The firm has a market cap of $2.86 billion, a P/E ratio of 21.72 and a beta of 0.66. The firm’s fifty day moving average is $242.58 and its 200 day moving average is $219.35.

Institutional Investors Weigh In On First Trust NYSE Arca Biotechnology Index Fund

A number of institutional investors have recently made changes to their positions in FBT. High Point Wealth Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $26,000. Russell Investments Group Ltd. increased its position in First Trust NYSE Arca Biotechnology Index Fund by 7,900.0% during the 3rd quarter. Russell Investments Group Ltd. now owns 160 shares of the company’s stock worth $29,000 after buying an additional 158 shares during the period. AG Campbell Advisory LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth $31,000. Cassaday & Co Wealth Management LLC acquired a new stake in shares of First Trust NYSE Arca Biotechnology Index Fund during the first quarter worth $34,000. Finally, Parallel Advisors LLC boosted its position in shares of First Trust NYSE Arca Biotechnology Index Fund by 1,300.0% in the first quarter. Parallel Advisors LLC now owns 182 shares of the company’s stock valued at $37,000 after acquiring an additional 169 shares during the period.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.